These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10645033)

  • 21. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus.
    Oz SG; Guven GS; Kilicarslan A; Calik N; Beyazit Y; Sozen T
    J Natl Med Assoc; 2006 Oct; 98(10):1598-604. PubMed ID: 17052049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
    Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
    Di Somma C; Colao A; Di Sarno A; Klain M; Landi ML; Facciolli G; Pivonello R; Panza N; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Mar; 83(3):807-13. PubMed ID: 9506732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results.
    Lumachi F; Orlando R; Fallo F; Basso SM
    In Vivo; 2012; 26(6):1041-4. PubMed ID: 23160690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship of iron overload to bone mass density and bone turnover in postmenopausal women with fragility fractures of the hip].
    Zhang LL; Jiang XF; Ai HZ; Jin ZD; Xu JX; Wang B; Xu W; Xie ZG; Zhou HB; Dong QR; Xu YJ
    Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):518-21. PubMed ID: 24091266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of 3 methods of measurement of blood pressure in insulin-dependent diabetic patients with or without incipient diabetic nephropathy].
    Hallab M; Berrut G; Chameau AM; Suraniti S; Marre M; Fressinaud P
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1157-9. PubMed ID: 1482251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria.
    Selby PL; Shearing PA; Marshall SM
    Diabet Med; 1995 Mar; 12(3):240-3. PubMed ID: 7758261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
    Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone loss and turnover after cardiac transplantation.
    Shane E; Rivas M; McMahon DJ; Staron RB; Silverberg SJ; Seibel MJ; Mancini D; Michler RE; Aaronson K; Addesso V; Lo SH
    J Clin Endocrinol Metab; 1997 May; 82(5):1497-506. PubMed ID: 9141540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous compliance and the venodilatory effect of nitroglycerin in insulin-dependent diabetic patients with and without (incipient) nephropathy.
    Schaper NC; Houben AJ; Schoon Y; Kooman JP; Huvers FC; Nieuwenhuijzen Kruseman AC
    Eur J Clin Invest; 1994 Jun; 24(6):382-7. PubMed ID: 7957490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of Serum Bone Metabolism Indexes and Ultrasonic Bone Mineral Density in Patients with Diabetic Nephropathy at Different Stages and their effects on Diabetic Renal Microvascular Complications.
    Han L; Wang S; Ma J; Song N; Wang Z; Yao M
    Pak J Med Sci; 2023; 39(3):656-661. PubMed ID: 37250586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is bone mineral density paradoxically increased in early stage of diabetic nephropathy?
    Koshiyama H; Tanaka K; Nakao K
    Arch Intern Med; 1999 May; 159(10):1145. PubMed ID: 10335699
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bone turnover and bone density in type 1 diabetics in the initial stages of diabetic nephropathy].
    Pontuch P; Payer J; Killinger Z; Toserova E; Listiakova D
    Bratisl Lek Listy; 1999 Aug; 100(8):445-8. PubMed ID: 10645033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.
    Olmos JM; Pérez-Castrillón JL; García MT; Garrido JC; Amado JA; González-Macías J
    Bone Miner; 1994 Jul; 26(1):1-8. PubMed ID: 7950501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients.
    Chen H; Li X; Yue R; Ren X; Zhang X; Ni A
    Diabetes Res Clin Pract; 2013 May; 100(2):272-6. PubMed ID: 23522918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
    Mitra D; Elvins DM; Collins AJ
    J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.